Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".

Singh S, Furberg CD. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease". Arch Intern Med. 2011 May 23; 171(10):920-2.

View in: PubMed

subject areas

Acute Disease
Administration, Inhalation
Aged
Case-Control Studies
Cholinergic Antagonists
Female
Follow-Up Studies
Humans
Incidence
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive
Reference Values
Risk Assessment
Safety Management
Scopolamine Derivatives
Tiotropium Bromide
Urinary Retention

authors with profiles

Sonal Singh MD, MPH